Pathogenesis and Treatment of Sickle Cell Disease (Q41587302)

4 October 2017

1 reference

title

Pathogenesis and treatment of sickle cell disease (English)

1 reference

4 October 2017

Pathogenesis and Treatment of Sickle Cell Disease (English)

1 reference

Crossref

https://api.crossref.org/works/10.1056/NEJM199709113371107

14 November 2024

0 references

H. F. Bunn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9287233

14 November 2024

language of work or name

English

0 references

publication date

1 September 1997

1 reference

4 October 2017

11 September 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9287233

full work available at URL

14 November 2024

http://www.nejm.org/doi/pdf/10.1056/NEJM199709113371107

1 reference

Crossref

https://api.crossref.org/works/10.1056/NEJM199709113371107

The New England Journal of Medicine

14 November 2024

published in

1 reference

4 October 2017

volume

337

1 reference

4 October 2017

1 reference

4 October 2017

page(s)

762-769

1 reference

Sickle cell anemia, a molecular disease

4 October 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.110.2865.543

Three-dimensional reconstruction of the 14-filament fibers of hemoglobin S

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

β-Chain contact sites in the haemoglobin S polymer

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

The effects of alpha chain mutations cis and trans to the beta6 mutation on the polymerization of sickle cell haemoglobin

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Supersaturation in sickle cell hemoglobin solutions

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Partially oxygenated sickled cells: sickle-shaped red cells found in circulating blood of patients with sickle cell disease

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Determination of deoxyhemoglobin S polymer in sickle erythrocytes upon deoxygenation

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Intracellular polymerization of sickle hemoglobin. Effects of cell heterogeneity

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Kinetics and Mechanism of Deoxyhemoglobin S Gelation: A New Approach to Understanding Sickle Cell Disease

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

A mathematical model of the volume, pH, and ion content regulation in reticulocytes. Application to the pathophysiology of sickle cell dehydration

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Regulation of erythrocyte cation and water content in sickle cell anemia

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Volume-dependent and NEM-stimulated K+,Cl- transport is elevated in oxygenated SS, SC and CC human red cells.

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Compartmentalization of sickle-cell calcium in endocytic inside-out vesicles

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Sickle Cell Vaso-Occlusion

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Potassium Cyanate as an Inhibitor of the Sickling of Erythrocytes In Vitro

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Diaspirins that crosslink .beta. chains of hemoglobin: bis(3,5-dibromosalicyl) succinate and bis(3,5-dibromosalicyl) fumarate

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Physiological and x-ray studies of potential antisickling agents

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

A Study of Induced Hyponatremia in the Prevention and Treatment of Sickle-Cell Crisis

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Pain in sickle cell disease. Rates and risk factors

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Progress in Clinical and Biological Research

14 November 2024

134

475

Dover GJ

1983

1 reference

Crossref

https://api.crossref.org/works/10.1056/NEJM199709113371107

Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Hematologic Responses of Patients with Sickle Cell Disease to Treatment with Hydroxyurea

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Treatment of sickle cell anemia with hydroxyurea and erythropoietin

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Augmentation by Erythropoietin of the Fetal-Hemoglobin Response to Hydroxyurea in Sickle Cell Disease

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Delay in the fetal globin switch in infants of diabetic mothers

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Bone marrow transplantation for sickle cell disease.

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

Bone marrow transplantation in sickle cell anemia--the dilemma of choice

14 November 2024

1 reference

https://api.crossref.org/works/10.1056/NEJM199709113371107

14 November 2024

Identifiers

1 reference

release_la4xuh6of5b5ffh2s6hgrhcvje

4 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/la4xuh6of5b5ffh2s6hgrhcvje

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference